Publication: HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease
Open/View Files
Date
2010
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Vunjak-Novakovic, Gordana, Sangeeta Bhatia, Christopher Chen, and Karen Hirschi. 2010. “HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease.” Stem Cell Research & Therapy 4 (Suppl 1): S8. doi:10.1186/scrt369. http://dx.doi.org/10.1186/scrt369.
Research Data
Abstract
Our project team is developing an integrated microphysiological platform with functionally connected vascular, liver and cardiac microtissues derived from a single line of human pluripotent stem cells. The platform enables functional representation of human physiology in conjunction with real-time biological readouts (via imaging and homologous reporters for all three cell phenotypes) and compatibility with high-throughput/high-content analysis. In this paper, we summarize progress made over the first year of the grant.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service